Clinical importance of anti-Ro52 antibody for polymyositis and dermatomyositis.
Sugita T, Tsuboi H, Sugita N, Akiyoshi R, Kuroda Y, Kawashima A, Kawashima F, Tabuchi D, Honda F, Ohyama A, Abe S, Kitada A, Asashima H, Miki H, Hagiwara S, Kondo Y, Matsumoto I.
Sugita T, et al.
Mod Rheumatol. 2024 May 28:roae052. doi: 10.1093/mr/roae052. Online ahead of print.
Mod Rheumatol. 2024.
PMID: 38804908